Media

Thetford Mines, Quebec – November 17, 2025 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”), a leader in innovative technological solutions for healthcare professionals, is pleased to announce the official opening of its U.S. subsidiary to launch, starting in 2026, the commercialization of Medherize, its therapeutic monitoring platform specialized in oncology. This strategic expansion positions KDA in one of the world’s largest specialty drug markets, valued at more than USD 243 billion in 2023.

Thetford Mines, Quebec – May 29, 2025 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”), a leader in innovative technological solutions for healthcare professionals, is pleased to announce the closing of a private placement with accredited investors totaling 8,800,000 units (the “Units”) at a price of $0.25 per Unit for total gross proceeds of $2,200,000 (the “Private Placement”).

Thetford Mines, Quebec – May 21, 2025 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”), a leader in innovative technological solutions for healthcare professionals, is pleased to announce that its Adherize+ platform, designed to optimize patient follow-up and care coordination, has officially received certification from Dossier Santé Québec (“DSQ”). This authorization marks a major step toward full production deployment.

Thetford Mines, Quebec – April 15, 2025 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”), a leader in innovative technological solutions for healthcare professionals, is pleased to announce that it has reached the final phase in the certification process for its Medherize platform’s integration with the Dossier Santé Québec (“DSQ”).

Thetford Mines, Quebec – February 24, 2025 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”), a leader in innovative technological solutions for healthcare professionals, is pleased to announce the voting results of the annual general meeting of shareholders (the “Meeting”) held on February 20, 2025, in Quebec.